<DOC>
	<DOCNO>NCT01218100</DOCNO>
	<brief_summary>This study evaluate safety efficacy first-line treatment free combination ( two separate pill ) nebivolol lisinopril patient stage 2 diastolic hypertension ( DBP &gt; = 100 mmHg ) .</brief_summary>
	<brief_title>Efficacy Safety Study Evaluate Combination Therapy With Nebivolol Lisinopril v . Placebo Monotherapy Patients With Stage 2 Diastolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>male female outpatient 18 64 year age Females must postmenopausal , pregnant use approved contraceptive regimen stage 2 diastolic hypertension ( DBP &gt; = 100 mmHg ) secondary hypertension evidence concurrent disease condition might interfere conduct study participation investigational drug study within 30 day 5 halflives , whichever longer , Screening ( Visit 1 ) . history hypersensitivity nebivolol βblockers , contraindication βblocker use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>